Literature DB >> 22981331

Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.

Xiaojuan Chao1, Xixin He, Yilin Yang, Xie Zhou, Minghua Jin, Shu Liu, Zhiyi Cheng, Peiqing Liu, Yuting Wang, Jianchen Yu, Yi Tan, Yingjuan Huang, Jian Qin, Simona Rapposelli, Rongbiao Pi.   

Abstract

A novel series of tacrine-caffeic acid hybrids (5a-f) were designed and synthesized by combining caffeic acid (CA) with tacrine. The antioxidant study revealed that all the hybrids have much more antioxidant capacities compared to CA. Among these compounds, 5e showed the highest selectivity in inhibiting acetylcholinesterase (AChE) over butyrylcholinesterase (BuChE). Enzyme kinetic study had suggested that 5e binds to both catalytic (CAS) and peripheral anionic sites (PAS) of AChE. Moreover, compound 5e also inhibited self- or AChE-induced β-amyloid(1-40) aggregation, as well as had potent neuroprotective effects against H(2)O(2)- and glutamate- induced cell death with low toxicity in HT22 cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981331     DOI: 10.1016/j.bmcl.2012.08.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  17 in total

1.  Protective effects of caffeic acid against hypothalamic neuropeptides alterations induced by malathion in rat.

Authors:  Raja Rezg; Bessem Mornagui; Jana Sopkova-de Oliveira Santos; Fabienne Dulin; Saloua El-Fazaa; Noomen Ben El-Haj; Ronan Bureau; Najoua Gharbi
Journal:  Environ Sci Pollut Res Int       Date:  2014-11-18       Impact factor: 4.223

2.  Annona atemoya leaf extract ameliorates cognitive impairment in amyloid-β injected Alzheimer's disease-like mouse model.

Authors:  Hye-Sun Lim; Yu Jin Kim; Eunjin Sohn; Jiyeon Yoon; Bu-Yeo Kim; Soo-Jin Jeong
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-03

3.  Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease.

Authors:  Matteo Scipioni; Graeme Kay; Ian L Megson; Paul Kong Thoo Lin
Journal:  Medchemcomm       Date:  2019-04-08       Impact factor: 3.597

Review 4.  Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.

Authors:  Natalia Guzior; Anna Wieckowska; Dawid Panek; Barbara Malawska
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

5.  Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease.

Authors:  Kris Simone Tranches Dias; Claudio Viegas
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

Review 6.  Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.

Authors:  Wen-Yu Wu; Yu-Chen Dai; Nian-Guang Li; Ze-Xi Dong; Ting Gu; Zhi-Hao Shi; Xin Xue; Yu-Ping Tang; Jin-Ao Duan
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

7.  Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.

Authors:  Katarina Spilovska; Jan Korabecny; Vendula Sepsova; Daniel Jun; Martina Hrabinova; Petr Jost; Lubica Muckova; Ondrej Soukup; Jana Janockova; Tomas Kucera; Rafael Dolezal; Eva Mezeiova; Daniel Kaping; Kamil Kuca
Journal:  Molecules       Date:  2017-06-16       Impact factor: 4.411

8.  New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease.

Authors:  Rajeshwari Rajeshwari; Karam Chand; Emanuel Candeias; Sandra M Cardoso; Sílvia Chaves; M Amélia Santos
Journal:  Molecules       Date:  2019-02-07       Impact factor: 4.411

9.  Tacrine, Trolox and Tryptoline as Lead Compounds for the Design and Synthesis of Multi-target Agents for Alzheimer's Disease Therapy.

Authors:  Gerard A K Teponnou; Jacques Joubert; Sarel F Malan
Journal:  Open Med Chem J       Date:  2017-01-31

10.  Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates.

Authors:  Luca Piemontese; Daniel Tomás; Asha Hiremathad; Vito Capriati; Emanuel Candeias; Sandra M Cardoso; Sílvia Chaves; M Amélia Santos
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.